Selective Laser Trabeculoplasty (SLT)
Selective Laser Trabeculoplasty (SLT) is an advanced treatment option for glaucoma patients that lowers eye pressure and increases fluid drainage. This procedure offers a simple solution to glaucoma symptoms through a minimally invasive procedure with no side effects, scarring or pain.
The SLT procedure is effective for almost all patients with just one session. It has been performed successfully in Europe for the past 10 years and is now FDA approved for use in the US. It is performed in the office and takes just a few minutes, providing long-term results through the use of a low-energy laser beam.
SLT is most effective for patients unable to keep up with a daily eye drop treatment because of its cost, inconvenience or side effects. SLT controls glaucoma symptoms for up to 5 years with no need for additional medication, and relieves symptoms by promoting the body's natural healing response. There are no major risks or complications associated with SLT and the procedure is covered by most insurance companies.